191 results on '"Alexander, Kevin M."'
Search Results
2. High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy with Cardiovascular Deep Learning
3. Outcomes with guideline-directed medical therapy and cardiac implantable electronic device therapies for patients with heart failure with reduced ejection fraction
4. Should We Systematically Screen for the Amyloidogenic V142I Variant?
5. Pulling at the heart: COVID-19, race/ethnicity and ongoing disparities
6. Proteotoxicity and Autophagy in Neurodegenerative and Cardiovascular Diseases
7. Abstract 13090: Clinical Burden of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the USA From 2004 to 2022
8. Abstract 13079: Prevalence and Incidence of Transthyretin Amyloid Cardiomyopathy in the USA From 2004 to 2022: An Observational Database Study
9. Abstract 11641: The Role of Inflammation in a Humanized Mouse Model of Transthyretin Cardiac Amyloidosis
10. Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias
11. Cardiac Amyloid Heart Disease in Racial/Ethnic Minorities: Focus on Transthyretin Amyloid Cardiomyopathy
12. Challenges and the innovations in the care of advanced heart failure patients during COVID-19
13. Mistaken Identity: Using Bone Scintigraphy to Diagnose Cardiac Amyloidosis in Patients With a Monoclonal Gammopathy
14. MicroRNA-21 regulates right ventricular remodeling secondary to pulmonary arterial pressure overload
15. Proteotoxicity and Autophagy in Neurodegenerative and Cardiovascular Diseases
16. Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation
17. Diagnosis and Treatment of Cardiac Amyloidosis Related to Plasma Cell Dyscrasias
18. Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association
19. Racial and Ethnic Disparities in Transthyretin Cardiac Amyloidosis
20. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial
21. Exploring Race and Sex Differences in Cardiac Sarcoidosis: “Dispare” no More
22. Utility of multimodality imaging in myopericarditis with aortitis
23. Advances in the Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy
24. Harnessing Cardiac Regeneration as a Potential Therapeutic Strategy for AL Cardiac Amyloidosis
25. Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
26. MP-453089-9 OUTCOMES WITH GUIDELINE-DIRECTED MEDICAL THERAPY AND CARDIAC IMPLANTABLE ELECTRONIC DEVICE THERAPIES FOR PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
27. Emerging Therapies for Transthyretin Cardiac Amyloidosis
28. Nurturing Diverse Generations of the Medical Workforce for Success With Authenticity: An Association of Black Cardiologists’ Roundtable
29. Effects of Body Mass Index on Presentation and Outcomes of COVID-19 among Heart Transplant and Left Ventricular Assist Device Patients: A Multi-Institutional Study
30. Novel pharmacotherapies for cardiac amyloidosis
31. Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis
32. High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep Learning
33. Defining Disease Progression in ATTR Cardiac Amyloidosis: Keeping It Simple
34. Effects of Body Mass Index on Presentation and Outcomes of COVID-19 among Heart Transplant and Left Ventricular Assist Device Patients: A Multi-Institutional Study.
35. Mistaken Identity
36. Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes
37. Transthyretin Cardiac Amyloidosis in the Elderly—Tip of a Heart Failure Iceberg?
38. Recipe for Success in Transthyretin Cardiomyopathy
39. Mechanical Circulatory Support for Advanced Heart Failure
40. Management of Cardiac Amyloidosis: Do’s and Don’ts
41. Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support
42. Challenges and the innovations in the care of advanced heart failure patients during COVID-19
43. Mortality From Heart Failure and Dementia in the United States: CDC WONDER 1999–2016
44. Decoding the Nanoenvironment in Cardiac Amyloidosis Through Proteomics
45. Bone Scintigraphy Imaging for Transthyretin Cardiac Amyloidosis
46. High-Frequency Ultrasound Echocardiography to Assess Zebrafish Cardiac Function
47. Trends and causes of hospitalizations in patients with amyloidosis
48. Grim Messenger: Virchow's Node Presenting with Virchow's Triad
49. Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015
50. True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.